Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Kangbuk Samsung Hospital

Status

Enrolling

Conditions

Diabetes Mellitus, Type 2

PreDiabetes

Treatments

Device: Freestyle Libre

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT06542627

KBSMC 2023-05-010

Details and patient eligibility

About

This study aimed to evaluate the effectiveness of use of Continuous Glucose Monitoring (CGM), combined with personalized dietary education and use of smartphone applications in improving glucose control and weight management.

Enrollment

420 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects over the age of 19
Patients with type 2 diabetes
- Fasting blood glucose ≥ 126 mg/dL or
- HbA1c ≥ 6.5% or
- Type 2 diabetes by clinical history and treated with antidiabetic medications or lifestyle Modifications
Patients with prediabetes
- Fasting blood glucose 100-125 mg/dL
- HbA1c 5.7-6.4%
Willing to participate in the study

Exclusion criteria

Subjects less than 19 years old
Patients with type 1 diabetes
Pregnant at the time of screening or planning to become pregnant during the study
Severe chronic diseases such as cancer, stroke, proliferative retinopathy, myocardial infarction, chronic renal disease, or amputation of a diabetic foot
Diagnosed with or treated for myocardial infarction, stroke, end-stage renal disease, liver failure, or chronic lung disease within the past year
Severe liver disease (e.g., cancer, liver cirrhosis, hepatitis B, hepatitis C)
Diseases of the biliary tract, thyroid disorders, autoimmune disorders, or acute infections
Planning to be admitted to a hospital within 2 months
Unable to participate in the mobile intervention study as determined by the investigator